Ying-Xin Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ying-Xin Qi has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
Qing-Ping Yao
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University
12 shared publicationsHan Bao
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
11 shared publicationsYue Han
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China
10 shared publicationsZong-Lai Jiang
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China
10 shared publicationsJi-Ting Liu
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
7 shared publicationsKai Huang
6 shared publications
Latest Publications
- 2 June 2026
- Published by Springer Nature
- Vol. 1512, 85-104
Vascular Mechanobiology: From Membrane to Nucleus
The vascular wall is continuously exposed to complex hemodynamic forces in vivo due to blood flow. Endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) experience distinct mechanical stresses, primarily shear stress and cyclic stretch, which are determined by their spatial organization within the vessel wall. Numerous studies indicate that abnormal (pathological) mechanical forces play crucial roles in EC and VSMC dysfunction during various cardiovascular diseases, including atherosclerosis, hypertension, and vein graft disease. This mechanical dysfunction represents a fundamental driver from vascular homeostasis to pathological remodeling. Hemodynamic forces activate membrane-associated mechanosensors, triggering a cascade of reactions through intricate intracellular signaling networks. Emerging evidence suggests that nuclear components, especially nuclear envelope proteins, nuclear pore complex, and chromatin, serve as important mechanosensitive elements that modulate chromatin dynamics, gene transcription, and ultimately cellular functions. However, research on the role of the nucleus in mechanotransduction remains in its early stages. Here, we briefly summarize the mechanosensors on the vascular cell membrane and particularly focus on the emerging roles of nuclear envelope proteins, nuclear pore complex, and chromatin in hemodynamic force-mediated vascular remodeling. These insights may advance our understanding of the molecular mechanisms underlying both vascular physiological homeostasis and pathophysiological remodeling, potentially leading to novel hemodynamic-based strategies for preventing and treating vascular diseases.
- 2 June 2026
- Published by Springer Nature
- Vol. 1512, 85-104
Vascular Mechanobiology: From Membrane to Nucleus
The vascular wall is continuously exposed to complex hemodynamic forces in vivo due to blood flow. Endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) experience distinct mechanical stresses, primarily shear stress and cyclic stretch, which are determined by their spatial organization within the vessel wall. Numerous studies indicate that abnormal (pathological) mechanical forces play crucial roles in EC and VSMC dysfunction during various cardiovascular diseases, including atherosclerosis, hypertension, and vein graft disease. This mechanical dysfunction represents a fundamental driver from vascular homeostasis to pathological remodeling. Hemodynamic forces activate membrane-associated mechanosensors, triggering a cascade of reactions through intricate intracellular signaling networks. Emerging evidence suggests that nuclear components, especially nuclear envelope proteins, nuclear pore complex, and chromatin, serve as important mechanosensitive elements that modulate chromatin dynamics, gene transcription, and ultimately cellular functions. However, research on the role of the nucleus in mechanotransduction remains in its early stages. Here, we briefly summarize the mechanosensors on the vascular cell membrane and particularly focus on the emerging roles of nuclear envelope proteins, nuclear pore complex, and chromatin in hemodynamic force-mediated vascular remodeling. These insights may advance our understanding of the molecular mechanisms underlying both vascular physiological homeostasis and pathophysiological remodeling, potentially leading to novel hemodynamic-based strategies for preventing and treating vascular diseases.
- Top Cited PapersOpen Access
- 6 February 2026
- Published by Elsevier in The Innovation
- Vol. 7 (4)
Transformative biomechanics and mechanobiology breakthroughs shaping the future of health and medicine
- 6 February 2026
- Published by Elsevier in The Innovation
- Vol. 7 (4)
Top Cited PapersOpen AccessTransformative biomechanics and mechanobiology breakthroughs shaping the future of health and medicine
- Open Access
Ventilator‐Induced Lung Injury: Mechanotransduction and Potential Therapeutic Targets
Mechanical ventilation (MV) serves as a critical intervention to maintain adequate gas exchange. Unfortunately, MV often leads to the development of ventilator‐induced lung injury (VILI). VILI pathogenesis involves alveolar‐capillary barrier disruption, dysregulated inflammation, and mechanotransduction‐driven cellular dysfunction, but the interplay of these mechanisms remains incompletely understood. Here, we review the types of mechanical stress in VILI, key signaling pathways implicated in MV‐induced lung injury, with particular emphasis on the impact of altered mechanical forces in VILI. Furthermore, we discuss the cell‐specific mechanisms in VILI. We also delineate the intricate molecular mechanisms that orchestrate intercellular communication in VILI. In addition, we discuss the limitations of current clinical strategies, and the identification of novel drug targets with transformative potential for treatment of VILI. Moreover, we summarize the current and emerging therapeutic strategies and discuss the existing knowledge gaps and future directions for VILI prevention. By integrating mechanical mechanistic insights with translational perspectives, this review identifies novel biomarkers and potential therapeutics to mitigate VILI. Our synthesis not only advances the understanding of VILI pathophysiology but also provides a framework for precision medicine approaches in critical care, ultimately optimizing MV outcomes.
Open AccessVentilator‐Induced Lung Injury: Mechanotransduction and Potential Therapeutic Targets
Mechanical ventilation (MV) serves as a critical intervention to maintain adequate gas exchange. Unfortunately, MV often leads to the development of ventilator‐induced lung injury (VILI). VILI pathogenesis involves alveolar‐capillary barrier disruption, dysregulated inflammation, and mechanotransduction‐driven cellular dysfunction, but the interplay of these mechanisms remains incompletely understood. Here, we review the types of mechanical stress in VILI, key signaling pathways implicated in MV‐induced lung injury, with particular emphasis on the impact of altered mechanical forces in VILI. Furthermore, we discuss the cell‐specific mechanisms in VILI. We also delineate the intricate molecular mechanisms that orchestrate intercellular communication in VILI. In addition, we discuss the limitations of current clinical strategies, and the identification of novel drug targets with transformative potential for treatment of VILI. Moreover, we summarize the current and emerging therapeutic strategies and discuss the existing knowledge gaps and future directions for VILI prevention. By integrating mechanical mechanistic insights with translational perspectives, this review identifies novel biomarkers and potential therapeutics to mitigate VILI. Our synthesis not only advances the understanding of VILI pathophysiology but also provides a framework for precision medicine approaches in critical care, ultimately optimizing MV outcomes.
- Open Access
- 22 January 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (2) , 116858
Extracellular matrix stiffness drives post-mitotic nuclear pore complex assembly to promote neuroblastoma pathogenesis
- 22 January 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (2) , 116858
Open AccessExtracellular matrix stiffness drives post-mitotic nuclear pore complex assembly to promote neuroblastoma pathogenesis
- Open Access
- 20 November 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (12) , 116578
MIAT-DHX9 spatiotemporal expression drives venous neointimal hyperplasia through nucleolar homeostasis and mitotic progression
- 20 November 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (12) , 116578
Open AccessMIAT-DHX9 spatiotemporal expression drives venous neointimal hyperplasia through nucleolar homeostasis and mitotic progression
- Open Access
- 5 July 2023
- Published by Elsevier in Mechanobiology in Medicine
- Vol. 1 (1)
Platelet-derived microvesicles drive vascular smooth muscle cell migration via forming podosomes and promoting matrix metalloproteinase-9 activity
- 5 July 2023
- Published by Elsevier in Mechanobiology in Medicine
- Vol. 1 (1)
Open AccessPlatelet-derived microvesicles drive vascular smooth muscle cell migration via forming podosomes and promoting matrix metalloproteinase-9 activity
- 26 October 2022
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 173, 101-114
Defective autophagy triggered by arterial cyclic stretch promotes neointimal hyperplasia in vein grafts via the p62/nrf2/slc7a11 signaling pathway
- 26 October 2022
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 173, 101-114
Defective autophagy triggered by arterial cyclic stretch promotes neointimal hyperplasia in vein grafts via the p62/nrf2/slc7a11 signaling pathway
- Open Access
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (11) , 4851-4865
Arterial cyclic stretch regulates Lamtor1 and promotes neointimal hyperplasia via circSlc8a1/miR-20a-5p axis in vein grafts
Rationale: Neointimal hyperplasia caused by dedifferentiation and proliferation of venous smooth muscle cells (SMCs) is the major challenge for restenosis after coronary artery bypass graft. Herein, we investigated the role of Lamtor1 in neointimal formation and the regulatory mechanism of non-coding RNA underlying this process.
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (11) , 4851-4865
Open AccessArterial cyclic stretch regulates Lamtor1 and promotes neointimal hyperplasia via circSlc8a1/miR-20a-5p axis in vein grafts
Rationale: Neointimal hyperplasia caused by dedifferentiation and proliferation of venous smooth muscle cells (SMCs) is the major challenge for restenosis after coronary artery bypass graft. Herein, we investigated the role of Lamtor1 in neointimal formation and the regulatory mechanism of non-coding RNA underlying this process.
- Open Access
- 16 September 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Platelet-Derived Microvesicles Promote VSMC Dedifferentiation After Intimal Injury via Src/Lamtor1/mTORC1 Signaling
Phenotypic switch of vascular smooth muscle cells (VSMCs) is important in vascular remodeling which causes hyperplasia and restenosis after intimal injury. Platelets are activated at injured intima and secrete platelet-derived microvesicles (PMVs). Herein, we demonstrated the role of PMVs in VSMC phenotypic switch and the potential underlying mechanisms. In vivo, platelets were locally adhered and activated at intimal injury site, while Lamtor1 was promoted and VSMCs were dedifferentiated. PMVs, collected from collagen-activated platelets in vitro which mimicked collagen exposure during intimal injury, promoted VSMC dedifferentiation, induced Lamtor1 expression, and activated mTORC1 signaling, reflected by the phosphorylation of two downstream targets, i.e., S6K and 4E-BP1. Knockdown of Lamtor1 with small interfering RNA attenuated these processes induced by PMVs. Based on the previously published proteomic data, Ingenuity Pathway Analysis revealed that Src may participate in regulating effects of PMVs. Src inhibitor significantly reversed the effects of PMVs on VSMC dedifferentiation, Lamtor1 expression and mTORC1 activation. Furthermore, in SMC-specific Lamtor1 knockout mice, intimal hyperplasia was markedly attenuated after intimal injury compared with the wild type. Our data suggested that PMVs secreted by activated platelets promoted VSMC dedifferentiation via Src/Lamtor1/mTORC1 signaling pathway. Lamtor1 may be a potential therapeutic target for intimal hyperplasia after injury.
- 16 September 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Open AccessPlatelet-Derived Microvesicles Promote VSMC Dedifferentiation After Intimal Injury via Src/Lamtor1/mTORC1 Signaling
Phenotypic switch of vascular smooth muscle cells (VSMCs) is important in vascular remodeling which causes hyperplasia and restenosis after intimal injury. Platelets are activated at injured intima and secrete platelet-derived microvesicles (PMVs). Herein, we demonstrated the role of PMVs in VSMC phenotypic switch and the potential underlying mechanisms. In vivo, platelets were locally adhered and activated at intimal injury site, while Lamtor1 was promoted and VSMCs were dedifferentiated. PMVs, collected from collagen-activated platelets in vitro which mimicked collagen exposure during intimal injury, promoted VSMC dedifferentiation, induced Lamtor1 expression, and activated mTORC1 signaling, reflected by the phosphorylation of two downstream targets, i.e., S6K and 4E-BP1. Knockdown of Lamtor1 with small interfering RNA attenuated these processes induced by PMVs. Based on the previously published proteomic data, Ingenuity Pathway Analysis revealed that Src may participate in regulating effects of PMVs. Src inhibitor significantly reversed the effects of PMVs on VSMC dedifferentiation, Lamtor1 expression and mTORC1 activation. Furthermore, in SMC-specific Lamtor1 knockout mice, intimal hyperplasia was markedly attenuated after intimal injury compared with the wild type. Our data suggested that PMVs secreted by activated platelets promoted VSMC dedifferentiation via Src/Lamtor1/mTORC1 signaling pathway. Lamtor1 may be a potential therapeutic target for intimal hyperplasia after injury.